Burkholderia pseudomallei kills Caenorhabditis elegans through virulence mechanisms distinct from intestinal lumen colonization

Virulence

Volumn 3, Issue 6, 2012, Pages 485-496

  Ooi, Soon Keat ^a   Lim, Tian Yeh ^a   Lee, Song Hua ^a,c   Nathan, Sheila ^a,b  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b MALAYSIA GENOME INSTITUTE   (Malaysia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Burkholderia pseudomallei; Caenorhabditis elegans; Host pathogen interaction; Intestinal lumen colonization; Toxin

Indexed keywords

ABC TRANSPORTER; BACTERIAL TOXIN; CARBENICILLIN; CHLORAMPHENICOL; GREEN FLUORESCENT PROTEIN; SEROTONIN; CAENORHABDITIS ELEGANS PROTEIN; PGP 5 PROTEIN, C ELEGANS; PGP-5 PROTEIN, C ELEGANS; PROTOZOAL PROTEIN; SMALL INTERFERING RNA;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BURKHOLDERIA PSEUDOMALLEI; CAENORHABDITIS ELEGANS; CELL KILLING; CONTROLLED STUDY; DEFECATION; ESCHERICHIA COLI; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOST PATHOGEN INTERACTION; INTESTINE; MELIOIDOSIS; NONHUMAN; PGP 5 GENE; PHARYNX; ANIMAL; BIOSYNTHESIS; BURKHOLDERIA INFECTION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; RNA INTERFERENCE; VIRULENCE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL TOXINS; BURKHOLDERIA INFECTIONS; BURKHOLDERIA PSEUDOMALLEI; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; ESCHERICHIA COLI; GREEN FLUORESCENT PROTEINS; HOST-PATHOGEN INTERACTIONS; INTESTINES; PROTOZOAN PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRULENCE;

EID: 84870563289     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.21808     Document Type: Article

References (54)

1. Galyov EE, Brett PJ, DeShazer D. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu Rev Microbiol 2010; 64:495-517; PMID:20528691; http://dx.doi.org/10.1146/annurev. micro.112408.134030
2. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18:383-416; PMID:15831829; http://dx. doi.org/10.1128/CMR.18.2.383-416.2005
3. Sprague LD, Neubauer H. Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation. J Vet Med B Infect Dis Vet Public Health 2004; 51:305-20; PMID:15525357; http://dx.doi.org/10.1111/j.1439-0450.2004.00797.x
4. Gan YH. Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy? J Infect Dis 2005; 192:1845-50; PMID: 16235187; http://dx.doi.org/10.1086/497382
5. Limmathurotsakul D, Peacock SJ. Melioidosis: a clinical overview. Br Med Bull 2011; 99:125-39; PMID:21558159; http://dx.doi.org/10.1093/bmb/ldr007
6. Schweizer HP, Peacock SJ. Antimicrobial drug-selection markers for Burkholderia pseudomallei and B. mallei. Emerg Infect Dis 2008; 14:1689-92; PMID: 18976550; http://dx.doi.org/10.3201/eid1411.080431
7. Inglis TJJ, Sagripanti JL. Environmental factors that affect the survival and persistence of Burkholderia pseudomallei. Appl Environ Microbiol 2006; 72:6865-75; PMID:16980433; http://dx.doi.org/10.1128/AEM.01036-06
8. Leelarasamee A. Recent development in melioidosis. Curr Opin Infect Dis 2004; 17:131-6; PMID: 15021053; http://dx.doi.org/10.1097/00001432-200404000-00011
9. Currie BJ. Burkholderia pseudomallei and Burkholderia mallei: melioidosis and glanders. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practices of Infectious Disease. 7th ed. Philadelphia: Elsevier Inc, 2010: 2869-77.
10. Hodgson KA, Morris JL, Feterl ML, Govan BL, Ketheesan N. Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes. Microbes Infect 2011; 13:1177-84; PMID:21835260; http://dx.doi.org/10. 1016/j.micinf.2011.07.008
11. Williams NL, Morris JL, Rush C, Govan BL, Ketheesan N. Impact of streptozotocin-induced diabetes on functional responses of dendritic cells and macrophages towards Burkholderia pseudomallei. FEMS Immunol Med Microbiol 2011; 61:218-27; PMID: 21204999; http://dx.doi.org/10.1111/j.1574-695X.2010.00767.x
12. Chin CY, Monack DM, Nathan S. Delayed activation of host innate immune pathways in streptozotocininduced diabetic hosts leads to more severe disease during infection with Burkholderia pseudomallei. Immunology 2012; 135:312-32; PMID:22136109; http://dx.doi.org/10.1111/j.1365-2567.2011.03544.x
13. Gravato-Nobre MJ, Hodgkin J. Caenorhabditis elegans as a model for innate immunity to pathogens. Cell Microbiol 2005; 7:741-51; PMID:15888078; http://dx.doi.org/10.1111/j.1462-5822.2005.00523.x
14. Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun 2009; 77:456-63; PMID:18955471; http://dx.doi.org/10.1128/IAI.00503-08
15. Irazoqui JE, Urbach JM, Ausubel FM. Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat Rev Immunol 2010; 10:47-58; PMID:20029447; http://dx.doi.org/10.1038/nri2689
16. Wiersinga WJ, Wieland CW, Roelofs JJTH, van der Poll T. MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS One 2008; 3:e3494; PMID:18946505; http://dx.doi.org/10.1371/journal.pone.0003494
17. O'Quinn AL, Wiegand EM, Jeddeloh JA. Burkholderia pseudomallei kills the nematode Caenorhabditis elegans using an endotoxin-mediated paralysis. Cell Microbiol 2001; 3:381-93; PMID:11422081; http://dx.doi.org/10.1046/j.1462-5822.2001.00118.x
18. Gan YH, Chua KL, Chua HH, Liu B, Hii CS, Chong HL, et al. Characterization of Burkholderia pseudomallei infection and identification of novel virulence factors using a Caenorhabditis elegans host system. Mol Microbiol 2002; 44:1185-97; PMID:12068805; http://dx.doi.org/10.1046/j.1365-2958.2002.02957.x
19. Lee SH, Ooi SK, Mahadi NM, Tan MW, Nathan S. Complete killing of Caenorhabditis elegans by Burkholderia pseudomallei is dependent on prolonged direct association with the viable pathogen. PLoS One 2011; 6:e16707; PMID:21408228; http://dx.doi.org/10.1371/journal.pone.0016707
20. van Schaik EJ, Tom M, Woods DE. Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: implications for the development of isocitrate lyase inhibitors as novel antimicrobials. Infect Immun 2009; 77:4275-83; PMID: 19620343; http://dx.doi.org/10.1128/IAI.00609-09
21. Alegado RA, Campbell MC, Chen WC, Slutz SS, Tan MW. Characterization of mediators of microbial virulence and innate immunity using the Caenorhabditis elegans host-pathogen model. Cell Microbiol 2003; 5:435-44; PMID:12814434; http://dx.doi.org/10.1046/j.1462-5822.2003.00287.x
22. Sifri CD, Begun J, Ausubel FM. The worm has turned-microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol 2005; 13:119-27; PMID:15737730; http://dx.doi.org/10.1016/j.tim.2005.01.003
23. Pizarro-Cerdá J, Cossart P. Bacterial adhesion and entry into host cells. Cell 2006; 124:715-27; PMID: 16497583; http://dx.doi.org/10.1016/j.cell.2006.02. 012
24. Mellies JL, Barron AMS, Haack KR, Korson AS, Oldridge DA. The global regulator Ler is necessary for enteropathogenic Escherichia coli colonization of Caenorhabditis elegans. Infect Immun 2006; 74:64-72; PMID:16368958; http://dx.doi.org/10.1128/IAI.74.1. 64-72.2006
25. Spanier B, Starke M, Higel F, Scherer S, Fuchs TM. Yersinia enterocolitica infection and tcaA-dependent killing of Caenorhabditis elegans. Appl Environ Microbiol 2010; 76:6277-85; PMID:20639372; http://dx.doi.org/10.1128/AEM.01274-10
26. Owen SJ, Batzloff M, Chehrehasa F, Meedeniya A, Casart Y, Logue CA, et al. Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis. J Infect Dis 2009; 199:1761-70; PMID:19456230; http://dx.doi.org/10.1086/599210
27. Lefebre MD, Valvano MA. Construction and evaluation of plasmid vectors optimized for constitutive and regulated gene expression in Burkholderia cepacia complex isolates. Appl Environ Microbiol 2002; 68: 5956-64; PMID:12450816; http://dx.doi.org/10. 1128/AEM.68.12.5956-5964.2002
28. Irazoqui JE, Troemel ER, Feinbaum RL, Luhachack LG, Cezairliyan BO, Ausubel FM. Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathog 2010; 6: e1000982; PMID:20617181; http://dx.doi.org/10. 1371/journal.ppat.1000982
29. Shapira M, Tan MW. Genetic analysis of Caenorhabditis elegans innate immunity. In: Ewbank J, Vivier E, eds. Methods in Molecular Biology. Totowa: Humana Press Inc, 2008; 429-42.
30. Avery L, Shtonda BB. Food transport in the C. elegans pharynx. J Exp Biol 2003; 206:2441-57; PMID: 12796460; http://dx.doi.org/10.1242/jeb.00433
31. Evans EA, Kawli T, Tan MW. Pseudomonas aeruginosa suppresses host immunity by activating the DAF-2 insulin-like signaling pathway in Caenorhabditis elegans. PLoS Pathog 2008; 4:e1000175; PMID:18927620; http://dx.doi.org/10.1371/journal.ppat.1000175
32. Alegado RA, Tan MW. Resistance to antimicrobial peptides contributes to persistence of Salmonella typhimurium in the C. elegans intestine. Cell Microbiol 2008; 10:1259-73; PMID:18221392; http://dx.doi.org/10.1111/j.1462-5822.2008.01124.x
33. Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, Inoue H, et al. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 2002; 297:623-6; PMID:12142542; http://dx. doi.org/10.1126/science.1073759
34. Branicky R, Hekimi S. What keeps C. elegans regular: the genetics of defecation. Trends Genet 2006; 22:571-9; PMID:16911844; http://dx.doi.org/10.1016/j.tig.2006.08.006
35. Hart AC, ed. Behavior (July 3, 2006), WormBook. The C. elegans Research Community, Wormbook, http://www.wormbook.org.
36. Williams SN, Locke CJ, Braden AL, Caldwell KA, Caldwell GA. Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans. Hum Mol Genet 2004; 13:2043-59; PMID:15254012; http://dx.doi. org/10.1093/hmg/ddh209
37. Srinivasan S, Sadegh L, Elle IC, Christensen AGL, Faergeman NJ, Ashrafi K. Serotonin regulates C. elegans fat and feeding through independent molecular mechanisms. Cell Metab 2008; 7:533-44; PMID: 18522834; http://dx.doi.org/10.1016/j.cmet.2008.04. 012
38. Kurz CL, Shapira M, Chen K, Baillie DL, Tan MW. Caenorhabditis elegans pgp-5 is involved in resistance to bacterial infection and heavy metal and its regulation requires TIR-1 and a p38 map kinase cascade. Biochem Biophys Res Commun 2007; 363:438-43; PMID: 17888400; http://dx.doi.org/10.1016/j.bbrc.2007.08. 190
39. Ramli NSK, Nathan S, Vadivelu J. Biofilm formation and Acyl-homoserine lactone production is varied amongst large and small colony variants of Burkholderia pseudomallei. PLoS ONE 2012; In press.
40. Allman E, Johnson D, Nehrke K. Loss of the apical VATPase a-subunit VHA-6 prevents acidification of the intestinal lumen during a rhythmic behavior in C. elegans. Am J Physiol Cell Physiol 2009; 297:C1071-81; PMID:19741196; http://dx.doi.org/10.1152/ajpcell.00284.2009
41. Avery L, Thomas JH. Introduction to C. elegans. In Riddle DL, Blumenthal T, Meyer BJ, Priess JR eds. C. elegans II. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1997: 679-81.
42. Millet ACM, Ewbank JJ. Immunity in Caenorhabditis elegans. Curr Opin Immunol 2004; 16:4-9; PMID: 14734103; http://dx.doi.org/10.1016/j.coi.2003.11. 005
43. Chávez V, Mohri-Shiomi A, Maadani A, Vega LA, Garsin DA. Oxidative stress enzymes are required for DAF-16-mediated immunity due to generation of reactive oxygen species by Caenorhabditis elegans. Genetics 2007; 176:1567-77; PMID:17483415; http://dx.doi.org/10.1534/genetics.107.072587
44. Zhang X, Zhang Y. Neural-immune communication in Caenorhabditis elegans. Cell Host Microbe 2009; 5:425-9; PMID:19454346; http://dx.doi.org/10.1016/j. chom.2009.05.003
45. Song BM, Avery L. Serotonin activates overall feeding by activating two separate neural pathways in Caenorhabditis elegans. J Neurosci 2012; 32:1920-31; PMID:22323705; http://dx.doi.org/10.1523/JNEUROSCI.2064-11.2012
46. Chase DL, Koelle MR. Biogenic amine neurotransmitters in C. elegans (February 20, 2007), WormBook, ed. The C. elegans Research Community, Wormbook, http://www.wormbook.org.
47. Rogers CM, Franks CJ, Walker RJ, Burke JF, Holden-Dye L. Regulation of the pharynx of Caenorhabditis elegans by 5-HT, octopamine, and FMRFamide-like neuropeptides. J Neurobiol 2001; 49:235-44; PMID: 11745661; http://dx.doi.org/10.1002/neu.1078
48. Ashcroft N, Golden A. CDC-25.1 regulates germline proliferation in Caenorhabditis elegans. Genesis 2002; 33:1-7; PMID:12001064; http://dx.doi.org/10.1002/gene.10083
49. Chen CY, Nace GW, Irwin PL. A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J Microbiol Methods 2003; 55:475-9; PMID:14529971; http://dx.doi.org/10.1016/S0167-7012(03)00194-5
50. Weinshenker D, Garriga G, Thomas JH. Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans. J Neurosci 1995; 75:6975-85; PMID:7472454
51. Lee SH, Chong CE, Lim BS, Chai SJ, Sam KK, Mohamed R, et al. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics. Diagn Microbiol Infect Dis 2007; 58:263-70; PMID:17350202; http://dx.doi.org/10.1016/j.diagmicrobio.2007.01.002
52. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974; 77:71-94; PMID:4366476
53. Shapira M, Hamlin BJ, Rong J, Chen K, Ronen M, Tan MW. A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc Natl Acad Sci U S A 2006; 103:14086-91; PMID: 16968778; http://dx.doi.org/10.1073/pnas. 0603424103
54. Simmer F, Tijsterman M, Parrish S, Koushika SP, Nonet ML, Fire A, et al. Loss of the putative RNAdirected RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Curr Biol 2002; 12:1317-9; PMID:12176360; http://dx.doi.org/10.1016/S0960-9822(02)01041-2